Defining the contractile prostanoid component in hyperosmolar-induced bronchoconstriction in human small airways

Prostaglandins Other Lipid Mediat. 2023 Oct:168:106761. doi: 10.1016/j.prostaglandins.2023.106761. Epub 2023 Jun 17.


Exercise-induced bronchoconstriction (EIB) is thought to be triggered by increased osmolarity at the airway epithelium. The aim of this study was to define the contractile prostanoid component of EIB, using an ex vivo model where intact segments of bronchi (inner diameter 0.5-2 mm) isolated from human lung tissue and subjected to mannitol. Exposure of bronchial segments to hyperosmolar mannitol evoked a contraction (64.3 ± 3.5 %) which could be prevented either by elimination of mast cells (15.8 ± 4.3 %) or a combination of cysteinyl leukotriene (cysLT1), histamine (H1) and thromboxane (TP) receptor antagonists (11.2 ± 2.3 %). Likewise, when antagonism of TP receptor was exchanged for inhibition of either cyclooxygenase-1 (8 ± 2.5 %), hematopoietic prostaglandin (PG)D synthase (20.7 ± 5.6 %), TXA synthase (14.8 ± 4.9 %), or the combination of the latter two (12.2 ± 4.6 %), the mannitol-induced contraction was prevented, suggesting that the TP-mediated component is induced by PGD2 and TXA2 generated by COX-1 and their respective synthases.

Keywords: Cyclooxygenase; Exercise-induced bronchoconstriction; Isolated bronchi; Mannitol; Mast cell; TP receptor.

Publication types

  • Review
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Bronchi
  • Bronchoconstriction*
  • Humans
  • Lung
  • Mannitol / pharmacology
  • Prostaglandins*


  • Prostaglandins
  • Mannitol